Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors-Reference-Cited by-同舟云学术

Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors

Published:2023-12 Issue:12 Volume:13 Page:4918-4933
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Fang Feifei,Dai Yang,Wang Hao,Ji Yinchun,Liang Xuewu,Peng Xia,Li Jiyuan,Zhao Yangrong,Li Chunpu,Wang Danyi,Li Yazhou,Zhang Dong,Zhang Dan,Geng Meiyu,Liu Hong,Ai Jing,Zhou Yu^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference68 articles.

1. AXL receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6;Varnum;Nature,1995

2. Giving AXL the axe: targeting AXL in human malignancy;Gay;Br J Cancer,2017

3. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer;Linger;Adv Cancer Res,2008

4. The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer;Graham;Nat Rev Cancer,2014

5. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications;Zhu;Mol Cancer,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment;Journal of Medicinal Chemistry;2024-06-24

2. Recent discovery and development of AXL inhibitors as antitumor agents;European Journal of Medicinal Chemistry;2024-06

3. Disrupting EGFR–HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome;International Journal of Molecular Sciences;2024-05-29

4. Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential;Archiv der Pharmazie;2024-05-16